NeoChord, Inc. Email Format
Medical Equipment ManufacturingMinnesota, United States11-50 Employees
NeoChord, Inc. is a privately held medical technology company based in Maple Grove, Minnesota, focused on advancing beating heart mitral valve repair for patients with mitral valve regurgitation. Its flagship device, the NeoChord Artificial Chordae Delivery System, has CE market clearance since December 2012, reflecting regulatory acceptance for this approach. Its customers are cardiac surgeons and medical centers seeking less invasive options for mitral valve repair in patients with regurgitation. In 2022 the company announced the launch of the Transcatheter NeXuS System for mitral chordal repair, along with positive one-year follow-up data.